Chimeric Therapeutics Ltd stock price live, this page displays ASX CHM stock exchange data. View the CHM premarket stock price ahead of the market session or assess the after hours quote.

Chimeric Therapeutics (ASX:CHM, "Chimeric" or the "Company"), an Australian leader in cell therapy, announced today that the U.S. Food and Drug Administration (FDA) has cleared the Investigational ...

CARGO Therapeutics (NASDAQ:CRGX – Get Free Report) was downgraded by research analysts at William Blair from an “outperform” ...

CARGO Therapeutics, Inc. (CRGX – Research Report) received a Hold rating and price target from William Blair analyst Sami Corwin today. The ...

Shaw, has introduced Qartemi, India's second CAR-T cell therapy, to treat B-cell Non-Hodgkin Lymphoma. This therapy is priced ...

In a report released today, Michael Yee from Jefferies downgraded CARGO Therapeutics, Inc. (CRGX – Research Report) to a Hold, with a price ...

CARGO Therapeutics, Inc.’s CRGX share price has dipped by 74.30%, which has investors questioning if this is right time to buy.

CARGO Therapeutics (NASDAQ:CRGX – Get Free Report) was downgraded by Jefferies Financial Group from a “buy” rating to a “hold ...